Tomkiel Melissa M.
Co-CEO and General Counsel
Tomkiel Melissa M. has filed 13 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, Tomkiel Melissa M. is listed as Co-CEO and General Counsel at Strata Critical Medical, Inc. Inside the rolling window, Tomkiel Melissa M. reported no open-market purchases and 1 open-market sale totaling $175K in SRTA.
Companies traded
Other insiders at SRTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$175K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tomkiel Melissa M. made?
Tomkiel Melissa M. has filed 13 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.
Which companies does Tomkiel Melissa M. trade?
Tomkiel Melissa M. has filed SEC Form 4 disclosures for 1 company, including SRTA.
When was Tomkiel Melissa M.'s most recent SEC Form 4 filing?
Tomkiel Melissa M.'s most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is Tomkiel Melissa M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tomkiel Melissa M. is listed as Co-CEO and General Counsel.
What is Tomkiel Melissa M.'s total buy and sell value in the current window?
Inside the rolling retention window, Tomkiel Melissa M. bought $0 and sold $175K based on SEC Form 4 filings.
What was Tomkiel Melissa M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 29,730 SRTA shares on 2026-06-08, worth $175K, per SEC Form 4 filings.